So Dope

In May 2026, So Dope concentrated 71.06% of sales in Flower with 78.39% year-over-year growth and 26.17% month-over-month expansion, while Vapor Pens held 7.91% share with a 54.38% month-over-month rebound against a -42.51% year-over-year decline. Concentrates accounted for 18.08% share but contracted -23.38% month-over-month, and Pre-Roll at 2.95% share slid -2.73% month-over-month alongside a -69.88% year-over-year drop; paired with a -1.58% brand-wide average price change and a rank of 90 in Flower in New York, the mix points to reliance on one growth engine while secondary formats cycle down. The pattern implies the category stack is widening volatility: Flower is pulling overall sales up 57.73% year-over-year, but the decline in Pre-Roll and Concentrates adds exposure to category-specific swings even as Vapor Pens shows tactical month-over-month recovery.

These shifts suggest a positioning anchored in mid-to-premium Flower (average Flower price $37.18) that can absorb price softness (-1.58% YoY brand average) while leveraging seasonal or promotional lifts, whereas the -23.38% month-over-month drop in Concentrates and the -69.88% year-over-year contraction in Pre-Roll indicate weak repeatability in smaller baskets. With rank 90 in New York Flower and Vapor Pens rebounding 54.38% month-over-month despite a steep -42.51% year-over-year gap, the brand’s defensible near-term posture is to double down where share is already 71.06% and selectively test cross-over bundles to stabilize the 18.08% and 2.95% niches; the implication is a core-led strategy that treats non-Flower as volatility dampeners rather than primary growth lanes.